Vaccines for the World
Vaccines for the World aims to produce a comprehensive oral history of the Oxford Vaccine Group’s (OVG) origins and impact, as well as of the Oxford COVID-19 response. Led by Dr Samantha Vanderslott and Dr Claas Kirchhelle, the project brings together key actors involved in establishing OVG, developing and trialling new vaccines ranging from meningococcus B to typhoid, and playing a leading role in Oxford’s Jenner Institute/OVG COVID-19 response.
We have three goals: (1) Produce a comprehensive account of the research environment, technological and scientific background, and wider political, economic, and social factors that enabled OVG to emerge as a leading global institute for vaccine development and trials. (2) Create a time capsule for future crisis responders interested in assessing how Oxford decisions on vaccine development, trials, and finance were made in the face of the substantial uncertainties and social disruption caused by SARS-CoV-2. (3) Assess ways forward for vaccine development and pandemic preparedness in light of recent experiences. We plan to launch a database of interviews and indexed transcripts.
Key Publications
Hill, M., Vanderslott, S., Volokha, A., & Pollard, A. J. (2022). Addressing vaccine inequities among Ukrainian refugees. The Lancet Infectious Diseases, 22(7), 935-936. doi.org/10.1016/S1473-3099(22)00366-8
Fairgrieve, D. Holm, S. Howells G. Kirchhelle, C. Vanderslott, S.(2021). In favour of a bespoke COVID-19 vaccines compensation scheme, The Lancet Infectious Diseases, ISSN 1473-3099, doi.org/10.1016/S1473-3099(21)00065-7